"Don't Fret the Sweat"
This article was originally published in The Rose Sheet
Executive Summary
Unilever refers parents of tweens to DontFretTheSweat.com, its educational Web site "filled with expert tips, money-saving offers and real-life stories about how parents are communicating and transitioning their tweens into confident and self-reliant young adults." In a survey conducted by KRC Research, 69% of tweens characterized talks with their parents as "very helpful," firm notes. It states: "In addition to facing more challenges and pressures, supporting research shows that kids are also entering puberty and experiencing biological milestones - including producing body odor - at an earlier age." Among other offerings from its Degree, Dove and Suave deodorant and antiperspirant lines, Unilever recommends Degree Girl, which "gets girls through every OMG moment with confidence" and now comes in a new scent - Degree Girl Friends Forever
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.